United Therapeutics Corp. (UTHR)

$ 396.50
   
  • Change Today:
    $-7.30
  • 52 Week High: $410.00
  • 52 Week Low: $274.70
  • Currency: US Dollars
  • Shares Issued: 43.56m
  • Volume: 124
  • Market Cap: $17,273m
  • RiskGrade: 132
  • Beta: 0.02

Latest ShareCast News

GlaxoSmithKline reportedly running the ruler over US rival

By Alexander Bueso

Date: Friday 04 Aug 2017

(ShareCast News) - GlaxoSmithKline may be studying a possible bid for US rival United Therapeutics, The Evening Standard reported citing City sources.

UTHR ShareCast News

No recent information was found.

UTHR Newspaper Links

Contracting 06-Dec-2007 Washington Post
United Therapeutics Shares Soar on FDA Report 02-Nov-2007 Washington Post
Study Raises Questions For United Therapeutics 27-Feb-2007 Washington Post
United Therapeutics Says Profit Plummets 70 Perc... 03-May-2006 Washington Post
United Therapeutics' Profit Surges 22-Feb-2006 Washington Post

UTHR Tips & Analysis

Test of Insomnia Drug Bolsters Vanda's Plan 16-Nov-2006 Washington Post
2005 Compensation For Top-Earning Executives Gre... 10-Jul-2006 Washington Post

UTHR News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

UTHR Market Data

Currency US Dollars
Share Price $ 396.50
Change Today $ -7.30
% Change -1.81 %
52 Week High $410.00
52 Week Low $274.70
Volume 124
Shares Issued 43.56m
Market Cap $17,273m
Beta 0.02
RiskGrade 132

What The Brokers Say

Strong Buy 6
Buy 4
Neutral 5
Sell 0
Strong Sell 0
Total 15
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 10-Sep-2025

Time Volume / Share Price
16:00 133,522 @ $396.50
15:59 100 @ $396.24
15:59 100 @ $396.30
15:59 155 @ $396.30
15:59 100 @ $396.45

Top of Page